SCHEMBL7080877

SCHEMBL7080877

COc1ccc2c(c1)c(OCC(=O)Nc1ccc(F)cc1F)nn2S(=O)(=O)c1ccc(C)c(O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
KCNA5 P22460 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 1/20 0.40
TP53 P04637 1/20 0.40
BRD4 O60885 1/20 0.40
PKM P14618 1/20 0.39
DDR1 Q08345 1/20 0.39
DDR2 Q16832 1/20 0.39
PDGFRA P16234 1/20 0.39
KDR P35968 1/20 0.39
CA4 P22748 1/20 0.38
MAOB P27338 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970855 0.91 KCNA5 (0.53) ALDH1A1KCNA5SMN1; SMN2MAPTRXFP1
SCHEMBL8042454 0.78 KCNA5 (0.42) ALDH1A1KCNA5SMN1; SMN2MAPTRXFP1
SCHEMBL6975922 0.76 NPC1 (0.43) ALDH1A1KCNA5SMN1; SMN2MAPTRXFP1
SCHEMBL6963364 0.76 MEN1 (0.54) ALDH1A1SMN1; SMN2MAPTTP53
SCHEMBL6972549 0.75 KMT2A (0.39) ALDH1A1MAPTCA12CA1CA2
SCHEMBL6977906 0.74 CNR2 (0.40) CA12CA1CA2CA9CA4
SCHEMBL6971590 0.74 AKR1C3 (0.38) ALDH1A1MAPTCA12CA1CA2
SCHEMBL6967854 0.73 PTPN11 (0.41) ALDH1A1MAPT
SCHEMBL6973904 0.73 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2MAPTRXFP1
SCHEMBL6978862 0.73 HTR6 (0.36) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1077947-B1 NOVEL 1,5 AND 3-O-SUBSTITUTED 1H-INDAZOLES WITH ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY, IMMUNO-MODULATING AND NEURO-PROTECTIVE EFFECT, METHOD FOR THE PRODUCTION AND USE THEREOF AS MEDICAMENTS DRESDEN ARZNEIMITTEL (DE) 2003-09-03 EP disclosed